Brett Robbins, MD
Family Medicine · Hattiesburg, MSNPI 1295843449
Payments from drug & device makers
Across 529 payments — averaging $14.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Pfizer$878
- Tris Pharma Inc$673
- Novo Nordisk$631
- Lilly USA, LLC$541
- Boehringer Ingelheim$509
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$280%
- Food & beverage$7,667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 130 | $1,541 |
| Pfizer | 66 | $878 |
| Tris Pharma Inc | 39 | $673 |
| Novo Nordisk | 51 | $631 |
| Lilly USA, LLC | 38 | $541 |
| Boehringer Ingelheim | 31 | $509 |
| Amgen | 29 | $451 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $320 |
| Johnson & Johnson | 17 | $306 |
| Merck | 16 | $261 |
| Teva Pharmaceuticals USA, Inc. | 7 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $167 |
| GSK | 10 | $151 |
| Novartis | 8 | $137 |
| Bayer | 5 | $92 |
| Genentech USA, Inc. | 6 | $88 |
| Phathom Pharmaceuticals, Inc. | 7 | $84 |
| Abbott | 4 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $83 |
| Exact Sciences | 4 | $78 |
| AstraZeneca | 5 | $77 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Shire North American Group Inc | 3 | $43 |
| Amarin Pharma, Inc. | 3 | $42 |
| Dynavax Technologies Corporation | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Shionogi Inc | 1 | $15 |
| Stryker | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $13 |
| IBSA Pharma Inc. | 1 | $13 |
How this compares
$7,695 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $95,302 |
| MounjaroTirzepatide | 64 | $88,004 |
| XifaxanRifaximin | 12 | $37,356 |
| FarxigaDapagliflozin Propanediol | 32 | $29,662 |
| JardianceEmpagliflozin | 31 | $25,365 |
| LinzessLinaclotide | 14 | $15,606 |
| EliquisApixaban | 15 | $13,941 |
| SynthroidLevothyroxine Sodium | 186 | $11,798 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $6,467 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $5,770 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 25 | $5,629 |
| Rosuvastatin Calcium | 430 | $4,506 |
| Irbesartan | 245 | $3,853 |
| Bupropion XlBupropion Hcl | 171 | $3,748 |
| Pantoprazole Sodium | 295 | $3,215 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $631 | $95,30271 claims |
| Lilly USA, LLCMounjaro | $541 | $88,00464 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $320 | $37,35612 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $509 | $31,13544 claims |
| AstraZenecaFarxiga | $77 | $29,66232 claims |
| AbbVieLinzess, Synthroid | $1,541 | $27,404200 claims |
| PfizerEliquis | $878 | $13,94115 claims |
| MerckJanumet | $261 | $6,46712 claims |
| GSKShingrix | $151 | $5,62925 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $1,995197 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Hattiesburg
- Rambod RouhbakhshHattiesburg$6M
- Omolara OtaigbeHattiesburg$17K
- Deborah CopelandHattiesburg$13K
- J DumasHattiesburg$12K
- Anny EvansHattiesburg$10K
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.